NYSE:CANF | Profit Breakdown | Can-Fite BioPharma Ltd.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$405,000.00-$9.95M-$9.83M-$9.83M
2024-12-31$674,000.00-$8.13M-$7.88M-$7.88M
2023-12-31$743,000.00-$8.2M-$7.63M-$7.63M
2022-12-31$810,000.00-$10.1M-$10.17M-$10.17M
2021-12-31$853,000.00-$12.84M-$12.62M-$12.62M
2020-12-31$763,000.00-$14.14M-$14.44M-$14.44M
2019-12-31$2.03M-$12.01M-$12.63M-$12.63M
2018-12-31$3.82M-$5.41M-$6.57M-$6.57M